Fagris Medica Limieted Profile
Key Indicators
- Authorised Capital ₹ 1.61 Cr
- Paid Up Capital ₹ 1.04 Cr
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 9.00 M
- Revenue Growth -92.32%
- Profit Growth 783.56%
- Ebitda -967.40%
- Net Worth 34.53%
- Total Assets -87.41%
About Fagris Medica Limieted
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH2008PTC271062
- Company No.
271062
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2008
- Date of AGM
15 Sep 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Fagris Medica Limieted?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sormistha Ghosh ![]() | Director | 25-Oct-2019 | Current |
Krishnan Parthasarathy ![]() | Director | 30-Jan-2018 | Current |
Alexander Alexander ![]() | Director | 07-Feb-2017 | Current |
Financial Performance of Fagris Medica Limieted.
Fagris Medica Private Limieted, for the financial year ended 2019, experienced significant reduction in revenue, with a 92.32% decrease. The company also saw a substantial improvement in profitability, with a 783.56% increase in profit. The company's net worth Soared by an impressive increase of 34.53%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Fagris Medica Limieted?
In 2019, Fagris Medica Limieted had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹0.90 Cr
Charges Breakdown by Lending Institutions
- The Federal Bank Limited : 0.90 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
17 Sep 2009 | The Federal Bank Limited | ₹9.00 M | Satisfied |
How Many Employees Work at Fagris Medica Limieted?
Unlock and access historical data on people associated with Fagris Medica Limieted, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Fagris Medica Limieted, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fagris Medica Limieted's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.